Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€33.87
31.03.23
€72.55
31.03.24
-24.45%
01.04.24

Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.88
26.03.24
-
26.03.25
-18.09%
31.03.24

Risky Investment
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
18.03.24
-
18.03.25
2.26%
30.03.24

Could be worthwhile Investment >10% per year
buy
Agenus Inc.

Start price
Target price
Perf. (%)
€1.45
29.03.23
€7.38
29.03.24
-61.53%
30.03.24

buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€52.40
29.03.23
€60.85
29.03.24
22.14%
30.03.24

buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€1.64
29.03.23
€11.06
29.03.24
69.95%
30.03.24

buy
Agenus Inc.

Start price
Target price
Perf. (%)
€1.45
29.03.23
€7.65
29.03.24
-61.53%
30.03.24

buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€52.40
29.03.23
€58.10
29.03.24
22.14%
30.03.24

buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€52.40
29.03.23
€80.23
29.03.24
22.14%
30.03.24

buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
16.03.24
€2.00
16.03.25
2.26%
30.03.24

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
buy
Chromadex Corp

Start price
Target price
Perf. (%)
€2.22
16.03.24
€4.00
16.03.25
53.15%
30.03.24

EBIT decline/stagnation expected
Revenue decline/stagnation expected
High valuation
Low dividend yield expected
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€4.89
16.03.24
€48.00
16.03.25
-12.06%
30.03.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.60
28.03.23
€23.06
28.03.24
609.42%
29.03.24

Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
17.03.24
€0.30
30.11.25
76.96%
28.03.24

Could be very worthwhile Investment >20% year
buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€13.19
27.03.23
€18.53
27.03.24
-44.50%
28.03.24

Brainstorm Cell

Start price
Target price
Perf. (%)
€1.72
26.03.23
-
26.03.24
-64.22%
27.03.24

buy
Orthofix Medical Inc.

Start price
Target price
Perf. (%)
€14.30
26.03.23
-
26.03.24
-13.29%
27.03.24

Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€0.65
26.03.23
-
26.03.24
144.58%
27.03.24

Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€1.47
25.03.23
-
25.03.24
64.08%
26.03.24

buy
Krystal Biotech

Start price
Target price
Perf. (%)
€73.00
25.03.23
-
25.03.24
113.70%
26.03.24

buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€35.09
25.03.23
-
25.03.24
-29.81%
26.03.24

buy
Heron Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.77
24.03.23
€9.29
24.03.24
53.64%
25.03.24

buy
Heron Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.77
24.03.23
€6.51
24.03.24
53.64%
25.03.24

buy
scPharmaceuticals

Start price
Target price
Perf. (%)
€8.00
23.03.23
€16.53
23.03.24
-41.00%
24.03.24

buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€6.35
21.03.23
€11.13
21.03.24
122.05%
22.03.24